CONSTELLATION BRANDS INC-A
STZNYSE🏆 #583 by market capEarnings Oct 6 · PreUS Equity
$112.16▼ $0.75 (−0.67%)
LiveTrack STZ
Get earnings, price moves & breaking news on Telegram
24h▼ 0.7%
7d▼ 4.6%
14d▼ 9.3%
30d▼ 14.2%
ytd▼ 18.7%
1y▼ 17.8%
🏦Market Cap
$19.16B
Mid Cap
📈Revenue Growth (YoY)
-10.5%
Declining
📊Gross Margin
52.6%
Healthy
💵FCF Margin
20.3%
Strong
⚖️P/S Ratio
2.1x
Cheap
Otter Score
88
Very Good
CONSTELLATION BRANDS INC-A
STZAnalyst Ratings
Price
$112.16
Total
46
Raised
4
Lowered
3
Avg PT
$158.50
H / L
$185 / $122
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
JP Morgan | Reiterated | Neutral | 2026-09-25 | $307.00 | +173.70% |
UBS | Reiterated | Buy | 2026-09-23 | $145.00 | +29.30% |
Citigroup | Reiterated | Buy | 2026-09-22 | $305.00 | +171.90% |
Barclays | Reiterated | Equal Weight | 2026-09-22 | $122.00 | +8.80% |
Evercore ISI Group | Reiterated | Outperform | 2026-09-21 | — | — |
TD Cowen | Reiterated | Buy | 2026-09-17 | — | — |
Jefferies | Reiterated | Hold | 2026-09-14 | $147.00 | +31.10% |
Deutsche Bank | Reiterated | Hold | 2026-09-11 | $136.00 | +21.30% |
Morgan Stanley | Reiterated | Equal Weight | 2026-07-02 | $158.00 | +40.90% |
RBC Capital | Reiterated | Outperform | 2026-07-02 | $289.00 | +157.70% |
Needham | Reiterated | Buy | 2026-07-02 | $185.00 | +64.90% |
B of A Securities | Reiterated | Underperform | 2026-07-02 | — | — |
Roth Capital | Reiterated | Buy | 2026-07-02 | $209.00 | +86.30% |
BMO Capital | Reiterated | Outperform | 2026-07-02 | $174.00 | +55.10% |
Piper Sandler | Reiterated | Neutral | 2026-07-01 | $160.00 | +42.70% |
Wells Fargo | Reiterated | Overweight | 2026-06-29 | $185.00 | +64.90% |
Bernstein | Reiterated | Outperform | 2026-01-09 | $180.00 | +60.50% |
Goldman Sachs | Reiterated | Buy | 2025-10-02 | $196.00 | +74.80% |
Roth MKM | Reiterated | Buy | 2025-04-03 | — | — |
Truist Securities | Reiterated | Hold | 2025-01-14 | — | — |
Argus Research | Upgraded | Hold → Buy | 2024-04-15 | $306.00 | +172.80% |
HSBC | Reiterated | Buy | 2024-04-12 | $285.00 | +154.10% |
Wedbush | Reiterated | Outperform | 2024-04-10 | $300.00 | +167.50% |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2023-01-06 | $200.00 | +78.30% |
Credit Suisse | Reiterated | Outperform | 2023-01-06 | $250.00 | +122.90% |
Redburn Partners | Reiterated | Buy | 2022-07-13 | — | — |
MKM Partners | Reiterated | Neutral | 2021-07-01 | — | — |
OTR Global | Downgraded | Positive → Mixed | 2021-06-18 | — | — |
Wolfe Research | Reiterated | Outperform | 2021-04-13 | — | — |
Atlantic Equities | Downgraded | Overweight → Neutral | 2020-10-14 | — | — |
Guggenheim | Reiterated | Neutral | 2020-06-25 | — | — |
CFRA | Reiterated | Hold | 2020-04-03 | $335.00 | +198.70% |
SunTrust Robinson Humphrey | Reiterated | Hold | 2019-07-01 | — | — |
Susquehanna | Upgraded | Negative → Neutral | 2019-01-07 | — | — |
Macquarie | Reiterated | Neutral | 2018-12-17 | — | — |
Bank of America | Reiterated | Buy | 2018-10-05 | — | — |
Stifel Nicolaus | Reiterated | Hold | 2018-07-02 | — | — |
Stifel | Reiterated | Hold | 2018-07-02 | — | — |
Nomura | Reiterated | Neutral | 2015-09-17 | — | — |
CLSA | Reiterated | Outperform | 2015-09-01 | — | — |
Societe Generale | Upgraded | Sell → Hold | 2015-01-13 | — | — |
Pivotal Research | Reiterated | Buy | 2014-10-20 | — | — |
DA Davidson | Reiterated | Buy | 2014-01-08 | — | — |
ISI Group | Upgraded | Buy → Strong Buy | 2013-05-16 | — | — |
Buckingham Research | Reiterated | Buy | 2013-01-16 | — | — |
Bank oferica | Reiterated | Buy | 2012-03-22 | — | — |
Institution
JP Morgan
Reiterated · Neutral · 2026-09-25
$307.00
+173.70%
UBS
Reiterated · Buy · 2026-09-23
$145.00
+29.30%
Citigroup
Reiterated · Buy · 2026-09-22
$305.00
+171.90%
Barclays
Reiterated · Equal Weight · 2026-09-22
$122.00
+8.80%
Evercore ISI Group
Reiterated · Outperform · 2026-09-21
—
—
TD Cowen
Reiterated · Buy · 2026-09-17
—
—
Jefferies
Reiterated · Hold · 2026-09-14
$147.00
+31.10%
Deutsche Bank
Reiterated · Hold · 2026-09-11
$136.00
+21.30%
Morgan Stanley
Reiterated · Equal Weight · 2026-07-02
$158.00
+40.90%
RBC Capital
Reiterated · Outperform · 2026-07-02
$289.00
+157.70%
Needham
Reiterated · Buy · 2026-07-02
$185.00
+64.90%
B of A Securities
Reiterated · Underperform · 2026-07-02
—
—
Roth Capital
Reiterated · Buy · 2026-07-02
$209.00
+86.30%
BMO Capital
Reiterated · Outperform · 2026-07-02
$174.00
+55.10%
Piper Sandler
Reiterated · Neutral · 2026-07-01
$160.00
+42.70%
Wells Fargo
Reiterated · Overweight · 2026-06-29
$185.00
+64.90%
Bernstein
Reiterated · Outperform · 2026-01-09
$180.00
+60.50%
Goldman Sachs
Reiterated · Buy · 2025-10-02
$196.00
+74.80%
Roth MKM
Reiterated · Buy · 2025-04-03
—
—
Truist Securities
Reiterated · Hold · 2025-01-14
—
—
Argus Research
Upgraded · Hold → Buy · 2024-04-15
$306.00
+172.80%
HSBC
Reiterated · Buy · 2024-04-12
$285.00
+154.10%
Wedbush
Reiterated · Outperform · 2024-04-10
$300.00
+167.50%
Cowen & Co.
Downgraded · Outperform → Market Perform · 2023-01-06
$200.00
+78.30%
Credit Suisse
Reiterated · Outperform · 2023-01-06
$250.00
+122.90%
Redburn Partners
Reiterated · Buy · 2022-07-13
—
—
MKM Partners
Reiterated · Neutral · 2021-07-01
—
—
OTR Global
Downgraded · Positive → Mixed · 2021-06-18
—
—
Wolfe Research
Reiterated · Outperform · 2021-04-13
—
—
Atlantic Equities
Downgraded · Overweight → Neutral · 2020-10-14
—
—
Guggenheim
Reiterated · Neutral · 2020-06-25
—
—
CFRA
Reiterated · Hold · 2020-04-03
$335.00
+198.70%
SunTrust Robinson Humphrey
Reiterated · Hold · 2019-07-01
—
—
Susquehanna
Upgraded · Negative → Neutral · 2019-01-07
—
—
Macquarie
Reiterated · Neutral · 2018-12-17
—
—
Bank of America
Reiterated · Buy · 2018-10-05
—
—
Stifel Nicolaus
Reiterated · Hold · 2018-07-02
—
—
Stifel
Reiterated · Hold · 2018-07-02
—
—
Nomura
Reiterated · Neutral · 2015-09-17
—
—
CLSA
Reiterated · Outperform · 2015-09-01
—
—
Societe Generale
Upgraded · Sell → Hold · 2015-01-13
—
—
Pivotal Research
Reiterated · Buy · 2014-10-20
—
—
DA Davidson
Reiterated · Buy · 2014-01-08
—
—
ISI Group
Upgraded · Buy → Strong Buy · 2013-05-16
—
—
Buckingham Research
Reiterated · Buy · 2013-01-16
—
—
Bank oferica
Reiterated · Buy · 2012-03-22
—
—
One row per institution · price target from the firm's latest published target